文献

J-GLOBAL ID：202102231754753399   整理番号：21A0137846

慢性骨髄性白血病患者におけるチロシンキナーゼ阻害剤の血漿濃度に対する血液透析と肝硬変の影響

The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia

著者 (15件)： Taniguchi Yasuhiro (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Takahashi Naoto (Departments of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan) ,  Miura Masatomo (Department of Pharmacy, Akita University Hospital, Japan) ,  Hirase Chikara (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Sueda Sanae (Department of Hematology, PL General Hospital, Japan) ,  Espinoza Jorge Luis (Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan) ,  Espinoza Jorge Luis (Faculty of Medicine, UNIDES University, Nicaragua) ,  Rai Shinya (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Nakayama Shoko (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Serizawa Kentaro (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Kumode Takahiro (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Watatani Yosaku (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Morita Yasuyoshi (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Tanaka Hirokazu (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan) ,  Matsumura Itaru (Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 59  号： 21  ページ： 2745-2749(J-STAGE)  発行年： 2020年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ・著者らは最近,血液透析(HD)を受けていた肝臓および腎機能...

シソーラス用語： ヒト ,...
準シソーラス用語： *チロシンキナーゼ阻害剤 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0137846&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (5件)： ダサチニブ ,  ボスチニブ ,  血液透析 ,  肝硬変 ,  プラズマ濃度

分類 (4件)： 腫ようの薬物療法  (GE03032C) ,  血液の腫よう  (GK04000M) ,  消化器の疾患  (GH03000W) ,  泌尿生殖器の疾患  (GM03000L)

物質索引 (2件)： ダサチニブ ,  ボスチニブ

引用文献 (23件)：

• 1. Druker BJ, Guihot F, O'Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355: 2408-2417, 2006.
• 2. Lang K, McGarry LJ, Huang H, Dorer D, Kaufman E, Knopf K. Mortality and vascular events among elderly patients with chronic myeloid leukemia: a retrospective analysis of linked SEER-medicare data. Clin Lymphoma Myeloma Leuk 16: 275-285.e1, 2016.
• 3. Saussele S, Krauss MP, Hehlmann R, et al. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV. Blood 126: 42-49, 2015.
• 4. Sohn SK, Oh SJ, Kim BS, et al. Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia. Leuk Lymphoma 52: 1024-1029, 2011.
• 5. Giles FJ, Yin OQ, Sallas WM, et al. Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia. Eur J Clin Pharmacol 69: 813-823, 2013.

タイトルに関連する用語 (6件)： 慢性骨髄性白血病 ,  患者 ,  チロシンキナーゼ阻害剤 ,  血漿濃度 ,  血液透析 ,  肝硬変